Ausgabe 5/2013
Inhalt (15 Artikel)
Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry
- Original article
Hatem Soliman, Bhupendra Rawal, Jimmy Fulp, Ji-Hyun Lee, Alexis Lopez, Marylin M. Bui, Farah Khalil, Scott Antonia, Harris G. Yfantis, Dong H. Lee, Tiffany H. Dorsey, Stefan Ambs
Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen
- Original article
Martin J. Cannon, Hannah E. Goyne, Pamela J. B. Stone, Laura J. MacDonald, Lindsey E. James, Everardo Cobos, Maurizio Chiriva-Internati
CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes
- Original article
Alessia Parodi, Florinda Battaglia, Francesca Kalli, Francesca Ferrera, Giuseppina Conteduca, Samuele Tardito, Silvia Stringara, Federico Ivaldi, Simone Negrini, Giacomo Borgonovo, Alchiede Simonato, Paolo Traverso, Giorgio Carmignani, Daniela Fenoglio, Gilberto Filaci
Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity
- Original article
Victoria L. Green, Anna Michno, Nicholas D. Stafford, John Greenman
Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6
- Original article
Philippe Ulsemer, Gemma Henderson, Kawe Toutounian, Anja Löffler, Jens Schmidt, Uwe Karsten, Michael Blaut, Steffen Goletz
A novel melittin-MhIL-2 fusion protein inhibits the growth of human ovarian cancer SKOV3 cells in vitro and in vivo tumor growth
- Original article
Mingjun Liu, Jinbao Zong, Zimin Liu, Ling Li, Xu Zheng, Bin Wang, Guirong Sun
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response
- Open Access
- Original Article
Chiara Camisaschi, Paola Filipazzi, Marcella Tazzari, Chiara Casati, Valeria Beretta, Lorenzo Pilla, Roberto Patuzzo, Andrea Maurichi, Agata Cova, Michele Maio, Vanna Chiarion-Sileni, Gabrina Tragni, Mario Santinami, Barbara Vergani, Antonello Villa, Emilio Berti, Ludmila Umansky, Philipp Beckhove, Viktor Umansky, Giorgio Parmiani, Licia Rivoltini, Chiara Castelli
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
- Original Article
Cristina Iclozan, Scott Antonia, Alberto Chiappori, Dung-Tsa Chen, Dmitry Gabrilovich
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine
- Focussed Research Review
Masanori Noguchi, Tetsuro Sasada, Kyogo Itoh
Circulating tumor cells as therapy-related biomarkers in cancer patients
- Focussed Research Review
Tobias M. Gorges, Klaus Pantel
FcγRΙΙB controls the potency of agonistic anti-TNFR mAbs
- Focussed Research Review
Ann L. White, H. T. Claude Chan, Ruth R. French, Stephen A. Beers, Mark S. Cragg, Peter W. M. Johnson, Martin J. Glennie
CD40 immunotherapy for pancreatic cancer
- Focussed Research Review
Robert H. Vonderheide, David L. Bajor, Rafael Winograd, Rebecca A. Evans, Lauren J. Bayne, Gregory L. Beatty
An introduction to mass cytometry: fundamentals and applications
- Focussed Research Review
Scott D. Tanner, Vladimir I. Baranov, Olga I. Ornatsky, Dmitry R. Bandura, Thaddeus C. George
Harnessing the antigenic fingerprint of each individual cancer for immunotherapy of human cancer: genomics shows a new way and its challenges
- Open Access
- Focussed Research Review
Pramod K. Srivastava, Fei Duan
Toward next-generation cancer immunotherapy: 10th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23–25, 2012
- Meeting Report
Björn-Philipp Kloke, Sarah Kutscher, Richard Rae, Pia Kvistborg, Cedrik M. Britten, Sine Reker Hadrup
